Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in Vogt-Koyanagi-Harada syndrome

被引：33
|
作者：
Farah, ME [1 ]
Costa, RA [1 ]
Muccioli, C [1 ]
Guia, TA [1 ]
Belfort, R [1 ]
机构：
[1] Univ Fed Sao Paulo, Paulista Sch Med, Dept Ophthalmol, Sao Paulo, Brazil
来源：
AMERICAN JOURNAL OF OPHTHALMOLOGY | 2002年 / 134卷 / 01期
关键词：
D O I：
10.1016/S0002-9394(02)01456-3
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
PURPOSE: To assess the role of photodynamic therapy using verteporfin in the treatment of subfoveal choroidal neovascularization in Vogt-Koyanagi-Harada syndrome. DESIGN: Interventional case report. METHODS: A 9-year-old patient with subfoveal choroidal neovascularization received a single photodynamic therapy with verteporfin session (one eye) and was prospectively followed with fluorescein angiography. RESULTS: A complete regression of the lesion was achieved within I week after treatment. Visual acuity improved from 20/800 to 20/320 by 6 months of follow, up. Fluorescein angiography disclosed unexpected retinal pigment epithelium alteration within the treatment area. CONCLUSION: Although regression of the choroidal neovascularization occurred, unpredicted findings involving normal retina in the vicinity of the lesion suggest that further studies are required to assess the clinical value of this treatment for subfoveal choroidal neovascularization in Vogt-Koyanagi-Harada syndrome. (C) 2002 by Elsevier Science Inc. All rights reserved.
引用
收藏
页码：137 / 139
页数：3
相关论文
共 50 条
  • [1] Photodynamic therapy for subfoveal choroidal neovascularisation in Vogt-Koyanagi-Harada disease
    Nowilaty, S. R.
    Bouhaimed, M.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2006, 90 (08) : 982 - 986
  • [2] Subretinal fibrosis and choroidal neovascularization in Vogt-Koyanagi-Harada syndrome
    Lertsumitkul, S
    Whitcup, SM
    Nussenblatt, RB
    Chan, CC
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1999, 237 (12) : 1039 - 1045
  • [3] Subretinal fibrosis and choroidal neovascularization in Vogt-Koyanagi-Harada syndrome
    S. Lertsumitkul
    Scott M. Whitcup
    Robert B. Nussenblatt
    Chi-Chao Chan
    Graefe's Archive for Clinical and Experimental Ophthalmology, 1999, 237 : 1039 - 1045
  • [4] Subfoveal choroidal neovascular membrane excision in Vogt-Koyanagi-Harada syndrome
    Foster, RE
    Knight, CD
    Lowder, CY
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2000, 20 (05): : 547 - 549
  • [5] Intravitreal bevacizumab for choroidal neovascularization secondary to Vogt-Koyanagi-Harada syndrome
    Wu, Lihteh
    Evans, Teodoro
    Saravia, Mario
    Schlaen, Ariel
    Couto, Cristobal
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2009, 53 (01) : 57 - 60
  • [6] Intravitreal bevacizumab for choroidal neovascularization secondary to Vogt-Koyanagi-Harada syndrome
    Lihteh Wu
    Teodoro Evans
    Mario Saravia
    Ariel Schlaen
    Cristobal Couto
    Japanese Journal of Ophthalmology, 2009, 53 : 57 - 60
  • [7] Surgical removal of subfoveal choroidal neovascular membranes in Vogt-Koyanagi-Harada syndrome
    Greve, MDJ
    Hillson, TR
    Hinz, BJ
    Tennant, MTS
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S871 - S871
  • [8] SUBRETINAL NEOVASCULARIZATION IN THE VOGT-KOYANAGI-HARADA SYNDROME
    OBER, RR
    SMITH, RE
    RYAN, SJ
    INTERNATIONAL OPHTHALMOLOGY, 1983, 6 (03) : 225 - 234
  • [9] The Use of Intravitreal Ranibizumab for Choroidal Neovascularization Associated with Vogt-Koyanagi-Harada Syndrome
    Kolomeyer, A. M.
    Roy, M. S.
    Chu, D. S.
    CASE REPORTS IN MEDICINE, 2011, 2011
  • [10] SUBFOVEAL CHOROIDAL THICKNESS AFTER TREATMENT OF VOGT-KOYANAGI-HARADA DISEASE
    Maruko, Ichiro
    Iida, Tomohiro
    Sugano, Yukinori
    Oyamada, Hiroshi
    Sekiryu, Tetsuju
    Fujiwara, Takamitsu
    Spaide, Richard F.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (03): : 510 - 517
12345